4.6 Article

Acute Kidney Injury Incidence, Recovery, and Long-term Kidney Outcomes Among Hospitalized Patients With COVID-19 and Influenza

Journal

KIDNEY INTERNATIONAL REPORTS
Volume 6, Issue 10, Pages 2565-2574

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ekir.2021.07.008

Keywords

acute kidney injury; COVID-19; influenza; mortality

Funding

  1. American Heart Association
  2. Mallinckrodt Pharmaceuticals

Ask authors/readers for more resources

The incidence of AKI and mortality rates are significantly higher in patients with COVID-19 compared to influenza patients during hospitalization. However, kidney recovery among long-term survivors appears to be similar in both groups.
Introduction: Acute kidney injury (AKI) is a common complication in patients with severe COVID-19. We sought to compare the AKI incidence and outcomes among patients hospitalized with COVID-19 and with influenza. Methods: This was a retrospective cohort study of patients with COVID-19 hospitalized between March and May 2020 and historical controls hospitalized with influenza A or B between January 2017 and December 2019 within a large health care system. Cox proportional hazards models were used to compare the risk of AKI during hospitalization. Secondary outcomes included AKI recovery, mortality, new-onset chronic kidney disease (CKD), and >= 25% estimated glomerular filtration rate (eGFR) decline. Results: A total of 2425 patients were included; 1091 (45%) had COVID-19, and 1334 (55%) had influenza. The overall AKI rate was 23% and 13% in patients with COVID-19 and influenza, respectively. Compared with influenza, hospitalized patients with COVID-19 had an increased risk of developing AKI (adjusted hazard ratio [aHR] = 1.58; 95% confidence interval [CI], 1.29-1.94). Patients with AKI were more likely to die in the hospital when infected with COVID-19 versus influenza (aHR = 3.55; 95% CI, 2.11-5.97). Among patients surviving to hospital discharge, the rate of AKI recovery was lower in patients with COVID-19 (aHR = 0.47; 95% CI, 0.36-0.62); however, among patients followed for >= 90 days, new-onset CKD (aHR = 1.24; 95% CI, 0.86-1.78) and >= 25% eGFR decline at the last follow-up (aHR = 1.36, 95% CI, 0.97- 1.90) were not significantly different between the cohorts. Conclusion: AKI and mortality rates are significantly higher in patients with COVID-19 than influenza; however, kidney recovery among long-term survivors appears to be similar.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available